212 related articles for article (PubMed ID: 23788464)
1. A harmonized approach to intracellular cytokine staining gating: Results from an international multiconsortia proficiency panel conducted by the Cancer Immunotherapy Consortium (CIC/CRI).
McNeil LK; Price L; Britten CM; Jaimes M; Maecker H; Odunsi K; Matsuzaki J; Staats JS; Thorpe J; Yuan J; Janetzki S
Cytometry A; 2013 Aug; 83(8):728-38. PubMed ID: 23788464
[TBL] [Abstract][Full Text] [Related]
2. Gating Harmonization Guidelines for Intracellular Cytokine Staining Validated in Second International Multiconsortia Proficiency Panel Conducted by Cancer Immunotherapy Consortium (CIC/CRI).
Price LS; Adamow M; Attig S; Fecci P; Norberg P; Reap E; Janetzki S; McNeil LK
Cytometry A; 2021 Jan; 99(1):107-116. PubMed ID: 33090656
[TBL] [Abstract][Full Text] [Related]
3. Harmonization of the intracellular cytokine staining assay.
Welters MJ; Gouttefangeas C; Ramwadhdoebe TH; Letsch A; Ottensmeier CH; Britten CM; van der Burg SH
Cancer Immunol Immunother; 2012 Jul; 61(7):967-78. PubMed ID: 22714399
[TBL] [Abstract][Full Text] [Related]
4. Toward development of a comprehensive external quality assurance program for polyfunctional intracellular cytokine staining assays.
Staats JS; Enzor JH; Sanchez AM; Rountree W; Chan C; Jaimes M; Chan RC; Gaur A; Denny TN; Weinhold KJ
J Immunol Methods; 2014 Jul; 409():44-53. PubMed ID: 24968072
[TBL] [Abstract][Full Text] [Related]
5. Standardization of cytokine flow cytometry assays.
Maecker HT; Rinfret A; D'Souza P; Darden J; Roig E; Landry C; Hayes P; Birungi J; Anzala O; Garcia M; Harari A; Frank I; Baydo R; Baker M; Holbrook J; Ottinger J; Lamoreaux L; Epling CL; Sinclair E; Suni MA; Punt K; Calarota S; El-Bahi S; Alter G; Maila H; Kuta E; Cox J; Gray C; Altfeld M; Nougarede N; Boyer J; Tussey L; Tobery T; Bredt B; Roederer M; Koup R; Maino VC; Weinhold K; Pantaleo G; Gilmour J; Horton H; Sekaly RP
BMC Immunol; 2005 Jun; 6():13. PubMed ID: 15978127
[TBL] [Abstract][Full Text] [Related]
6. Data analysis as a source of variability of the HLA-peptide multimer assay: from manual gating to automated recognition of cell clusters.
Gouttefangeas C; Chan C; Attig S; Køllgaard TT; Rammensee HG; Stevanović S; Wernet D; thor Straten P; Welters MJ; Ottensmeier C; van der Burg SH; Britten CM
Cancer Immunol Immunother; 2015 May; 64(5):585-98. PubMed ID: 25854580
[TBL] [Abstract][Full Text] [Related]
7. Quality assurance of intracellular cytokine staining assays: analysis of multiple rounds of proficiency testing.
Jaimes MC; Maecker HT; Yan M; Maino VC; Hanley MB; Greer A; Darden JM; D'Souza MP
J Immunol Methods; 2011 Jan; 363(2):143-57. PubMed ID: 20727897
[TBL] [Abstract][Full Text] [Related]
8. Setting objective thresholds for rare event detection in flow cytometry.
Richards AJ; Staats J; Enzor J; McKinnon K; Frelinger J; Denny TN; Weinhold KJ; Chan C
J Immunol Methods; 2014 Jul; 409():54-61. PubMed ID: 24727143
[TBL] [Abstract][Full Text] [Related]
9. Statistical methods for the assessment of EQAPOL proficiency testing: ELISpot, Luminex, and Flow Cytometry.
Rountree W; Vandergrift N; Bainbridge J; Sanchez AM; Denny TN
J Immunol Methods; 2014 Jul; 409():72-81. PubMed ID: 24456626
[TBL] [Abstract][Full Text] [Related]
10. The Immunology Quality Assessment Proficiency Testing Program for CD3⁺4⁺ and CD3⁺8⁺ lymphocyte subsets: a ten year review via longitudinal mixed effects modeling.
Bainbridge J; Wilkening CL; Rountree W; Louzao R; Wong J; Perza N; Garcia A; Denny TN
J Immunol Methods; 2014 Jul; 409():82-90. PubMed ID: 24911327
[TBL] [Abstract][Full Text] [Related]
11. VERITAS?: A time for VERIQAS™ and a new approach to training, education, and the quality assessment of CD4+ T lymphocyte counting (I).
Barnett D; Whitby L; Wong J; Louzao R; Reilly JT; Denny TN
Cytometry B Clin Cytom; 2012 Mar; 82(2):93-100. PubMed ID: 21998025
[TBL] [Abstract][Full Text] [Related]
12. Proficiency tests to evaluate the impact on assay outcomes of harmonized influenza-specific Intracellular Cytokine Staining (ICS) and IFN-ɣ Enzyme-Linked ImmunoSpot (ELISpot) protocols.
Waerlop G; Leroux-Roels G; Pagnon A; Begue S; Salaun B; Janssens M; Medaglini D; Pettini E; Montomoli E; Gianchecchi E; Lambe T; Godfrey L; Bull M; Bellamy D; Amdam H; Bredholt G; Cox RJ; Clement F
J Immunol Methods; 2023 Dec; 523():113584. PubMed ID: 37918618
[TBL] [Abstract][Full Text] [Related]
13. Development and implementation of a proficiency testing program for Luminex bead-based cytokine assays.
Lynch HE; Sanchez AM; D'Souza MP; Rountree W; Denny TN; Kalos M; Sempowski GD
J Immunol Methods; 2014 Jul; 409():62-71. PubMed ID: 24801479
[TBL] [Abstract][Full Text] [Related]
14. The CIMT-monitoring panel: a two-step approach to harmonize the enumeration of antigen-specific CD8+ T lymphocytes by structural and functional assays.
Britten CM; Gouttefangeas C; Welters MJ; Pawelec G; Koch S; Ottensmeier C; Mander A; Walter S; Paschen A; Müller-Berghaus J; Haas I; Mackensen A; Køllgaard T; thor Straten P; Schmitt M; Giannopoulos K; Maier R; Veelken H; Bertinetti C; Konur A; Huber C; Stevanović S; Wölfel T; van der Burg SH
Cancer Immunol Immunother; 2008 Mar; 57(3):289-302. PubMed ID: 17721783
[TBL] [Abstract][Full Text] [Related]
15. Harmonization and qualification of intracellular cytokine staining to measure influenza-specific CD4
Begue S; Waerlop G; Salaun B; Janssens M; Bellamy D; Cox RJ; Davies R; Gianchecchi E; Medaglini D; Montomoli E; Pettini E; Leroux-Roels G; Clement F; Pagnon A
Front Immunol; 2022; 13():982887. PubMed ID: 36341380
[TBL] [Abstract][Full Text] [Related]
16. A critical assessment for the value of markers to gate-out undesired events in HLA-peptide multimer staining protocols.
Attig S; Price L; Janetzki S; Kalos M; Pride M; McNeil L; Clay T; Yuan J; Odunsi K; Hoos A; Romero P; Britten CM;
J Transl Med; 2011 Jul; 9():108. PubMed ID: 21745365
[TBL] [Abstract][Full Text] [Related]
17. Flow cytometric lymphocyte subset enumeration: 10 years of external quality assessment in the Benelux countries.
Levering WH; van Wieringen WN; Kraan J; van Beers WA; Sintnicolaas K; van Rhenen DJ; Gratama JW
Cytometry B Clin Cytom; 2008 Mar; 74(2):79-90. PubMed ID: 17849485
[TBL] [Abstract][Full Text] [Related]
18. Results and harmonization guidelines from two large-scale international Elispot proficiency panels conducted by the Cancer Vaccine Consortium (CVC/SVI).
Janetzki S; Panageas KS; Ben-Porat L; Boyer J; Britten CM; Clay TM; Kalos M; Maecker HT; Romero P; Yuan J; Kast WM; Hoos A;
Cancer Immunol Immunother; 2008 Mar; 57(3):303-15. PubMed ID: 17721781
[TBL] [Abstract][Full Text] [Related]
19. Harmonization guidelines for HLA-peptide multimer assays derived from results of a large scale international proficiency panel of the Cancer Vaccine Consortium.
Britten CM; Janetzki S; Ben-Porat L; Clay TM; Kalos M; Maecker H; Odunsi K; Pride M; Old L; Hoos A; Romero P;
Cancer Immunol Immunother; 2009 Oct; 58(10):1701-13. PubMed ID: 19259668
[TBL] [Abstract][Full Text] [Related]
20. Categorizing and Establishing CD4 Service Equivalency: Testing of Residual, Archived External Quality Assessment Scheme Sample Panels Enables Accelerated Virtual Peer Laboratory Review.
Glencross DK; Coetzee LM
Cytometry B Clin Cytom; 2019 Sep; 96(5):404-416. PubMed ID: 30821061
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
